Literature DB >> 8961512

Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy.

S Kurikka1.   

Abstract

Haemophilus influenzae type b (Hib) capsular polysaccharide (PS) conjugated to tetanus toxoid (PRP-T) was given at 4 and 6 months of age and anti-Hib PS antibody response to the first and second dose of PRP-T was compared in groups that received diphtheria-tetanus-pertussis (DTP) vaccine either simultaneously with PRP-T (34 infants) or separately at 3, 4 and 5 months of age (49 infants). The geometric mean anti-Hib PS antibody concentration after the first dose of PRP-T given at 4 months of age was eightfold higher if the infants primed with DTP at 3 months of age than if the first dose of DTP was given together with the first dose of PRP-T (0.81 microgram ml-1 vs 0.11 microgram ml-1). The positive influence of DTP priming was seen also after the second dose of PRP-T given at 6 months of age (7.55 micrograms ml-1 vs 3.45 micrograms ml-1).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961512     DOI: 10.1016/s0264-410x(96)00025-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction.

Authors:  Mohamed Tashani; Sanjay Jayasinghe; Zitta B Harboe; Harunor Rashid; Robert Booy
Journal:  World J Clin Pediatr       Date:  2016-08-08

Review 2.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

3.  Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.

Authors:  L J Rubinstein; P A García-Ojeda; F Michon; H J Jennings; K E Stein
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.

Authors:  Govindaswami Ragupathi; Don M Coltart; Lawrence J Williams; Fusataka Koide; Ella Kagan; Jennifer Allen; Christina Harris; Peter W Glunz; Philip O Livingston; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-01       Impact factor: 11.205

5.  Immunogenicity of a promiscuous T cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the hapten.

Authors:  Mario T Schellenberger; Nathalie Grova; Sophie Farinelle; Stéphanie Willième; Dominique Revets; Claude P Muller
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

6.  Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.

Authors:  R Dagan; J Eskola; C Leclerc; O Leroy
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Carrier priming to improve pneumococcal disease control and reduce the international program's cost in children.

Authors:  Mohamed Tashani; Harunor Rashid; Kim Mulholland; Robert Booy
Journal:  Pneumonia (Nathan)       Date:  2016-09-27

8.  Peptide adjacent to glycosylation sites impacts immunogenicity of glycoconjugate vaccine.

Authors:  Zhongrui Ma; Huajie Zhang; Peng George Wang; Xian-Wei Liu; Min Chen
Journal:  Oncotarget       Date:  2017-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.